Compass Therapeutics, Inc. (CMPX)
0.8145
-0.02
(-2.26%)
USD |
NASDAQ |
Oct 21, 16:00
0.8306
+0.02
(+1.98%)
After-Hours: 20:00
Compass Therapeutics Net Income (Annual) : -66.49M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -66.49M |
| December 31, 2024 | -49.38M |
| December 31, 2023 | -42.49M |
| December 31, 2022 | -39.22M |
| Date | Value |
|---|---|
| December 31, 2021 | -82.18M |
| December 31, 2020 | -29.50M |
| December 31, 2019 | -34.74M |
| December 31, 2018 | -38.29M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Viking Therapeutics, Inc. | -359.64M |
| Capricor Therapeutics, Inc. | -105.04M |
| Ardelyx, Inc. | -61.60M |
| Biomea Fusion, Inc. | -61.80M |
| ARS Pharmaceuticals, Inc. | -171.30M |